Table 1 Characteristics of iLiNS-DYAD trial participants at ≤20 weeks gestation who were included in or excluded from the current cohort study
|  | Mean ± SD or n/n (%) |  | |
|---|---|---|---|
Included (n = 783) | Excluded (n = 537) | p | |
Maternal age (y) | 26.6 ± 5.4 | 26.9 ± 5.7 | 0.406 |
Nulliparous (%) | 260/783 (33.2%) | 186/537 (34.6%) | 0.589 |
Total school years completed (y) | 7.6 ± 3.4 | 7.7 ± 3.9 | 0.709 |
Married (%) | 720/783 (92.0%) | 504/537 (93.9%) | 0.263 |
Gestational age (wk) | 16.1 ± 3.0 | 16.1 ± 3.7 | 0.851 |
Male fetus (%)a | 372/783 (47.5%) | 189/376 (50.3%) | 0.379 |
Twin pregnancy (%)b | 15/783 (1.9%) | 7/457 (1.5%) | 0.619 |
BMI (kg/m2) | 24.8 ± 4.6 | 24.8 ± 4.5 | 0.939 |
Anemia (%, Hb < 100 g/L) | 112/783 (14.3%) | 73/537 (13.6%) | 0.715 |
Positive malaria test (%) | 74/783 (9.5%) | 60/536 (11.2%) | 0.303 |
Cortisol, nmol/L | 4.9 ± 2.7 | 4.5 ± 2.2 | 0.147 |
AGP, g/L | 0.65 ± 0.21 | 0.65 ± 0.22 | 0.916 |
CRP, mg/L | 7.2 ± 11.5 | 6.6 ± 11.7 | 0.336 |